Hemangi Sane

TL;DR: In this paper, a pilot clinical trial was conducted to evaluate the safety and efficacy of intravenous ozonised saline treatment in patients with moderate COVID-19 pneumonia, where 10 patients were administered 200ml freshly prepared ozonized saline intravenously over 1h once a day for 8 days along with standard medical treatment.

TL;DR: A 61 year old woman diagnosed with vascular dementia who was administered autologous bone marrow derived mononuclear cells, intrathecally shows sustained significant clinical improvements recorded by MMSE and FIM along with corroborating changes in PET CT scan of brain showing significantly improved metabolic activity.

TL;DR: Through this case report, it is demonstrated that treatment with autologous BMMNCs is safe, feasible and has the potential to ameliorate autism.

TL;DR: The clinical changes exhibited by BMMNCs transplantation even at a chronic stage in stroke substantiate their therapeutic potential, and provide foundation for further research.

TL;DR: Multiple doses of intrathecal autologous cell therapy along with rehabilitation and lithium, in addition to standard riluzole treatment is a novel approach for decelerating disease progression and qualitatively improving living conditions for ALS patients and their caregivers.